The 20 Best Cerebrotendinous Xanthomatosis Doctors in The United States

Terry Short is a primary care provider, practicing in Internal Medicine in Charlotte, North Carolina. Dr. Short is rated as an Experienced provider by MediFind in the treatment of Cerebrotendinous Xanthomatosis. His top areas of expertise are High Cholesterol, Hypertension, Familial Hypertension, and Glucocorticoid-Remediable Aldosteronism. Dr. Short is currently accepting new patients.

Thomas Batchelor is a primary care provider, practicing in Internal Medicine in Charlotte, North Carolina. Dr. Batchelor has been practicing medicine for over 32 years and is rated as a Distinguished provider by MediFind in the treatment of Cerebrotendinous Xanthomatosis. His top areas of expertise are Cholesteryl Ester Storage Disease, Lipidosis with Triglycerid Storage Disease, Lysosomal Acid Lipase Deficiency, and Cerebrotendinous Xanthomatosis.

. Dr. Pearlstein is rated as an Advanced provider by MediFind in the treatment of Cerebrotendinous Xanthomatosis. His top areas of expertise are Dementia, Alzheimer's Disease, Painful Swallowing, Gastrostomy, and Endoscopy.

. Dr. Flores is rated as an Experienced provider by MediFind in the treatment of Cerebrotendinous Xanthomatosis. Her top areas of expertise are Obesity in Children, Glucocorticoid-Remediable Aldosteronism, Hypertension, and Familial Hypertension.

Ritesh Ramdhani is a Neurologist in Great Neck, New York. Dr. Ramdhani is rated as an Advanced provider by MediFind in the treatment of Cerebrotendinous Xanthomatosis. His top areas of expertise are Movement Disorders, Parkinson's Disease, Focal Dystonia, Drug Induced Dyskinesia, and Deep Brain Stimulation.

Mitch Freeman is a primary care provider, practicing in Family Medicine in Yuma, Arizona. Dr. Freeman is rated as a Distinguished provider by MediFind in the treatment of Cerebrotendinous Xanthomatosis. His top areas of expertise are Lipidosis with Triglycerid Storage Disease, Wolman Disease, Chanarin-Dorfman Syndrome, and Lysosomal Acid Lipase Deficiency.

Pedro Penalo is a primary care provider, practicing in Palliative Medicine in Weslaco, Texas. Dr. Penalo is rated as a Distinguished provider by MediFind in the treatment of Cerebrotendinous Xanthomatosis. His top areas of expertise are Type 2 Diabetes (T2D), Hypertension, Familial Hypertension, and Glucocorticoid-Remediable Aldosteronism.

Florian Eichler is a Pediatric Neurologist in Boston, Massachusetts. Dr. Eichler is rated as a Distinguished provider by MediFind in the treatment of Cerebrotendinous Xanthomatosis. His top areas of expertise are Adrenoleukodystrophy (ALD), CACH Syndrome, Tay-Sachs Disease, Gangliosidosis, and Gastrostomy.

Marc Allen is a primary care provider, practicing in Internal Medicine and Hospital Medicine in Smithtown, New York. Dr. Allen is rated as an Advanced provider by MediFind in the treatment of Cerebrotendinous Xanthomatosis. His top areas of expertise are Cholesteryl Ester Storage Disease, Chanarin-Dorfman Syndrome, Cerebrotendinous Xanthomatosis, and Lysosomal Acid Lipase Deficiency.

Theresa Labarte is a Neurologist in Loma Linda, California. Dr. Labarte is rated as an Advanced provider by MediFind in the treatment of Cerebrotendinous Xanthomatosis. Her top areas of expertise are Lysosomal Acid Lipase Deficiency, Cerebrotendinous Xanthomatosis, Distal Median Nerve Dysfunction, and Myasthenia Gravis.

William Brown is a primary care provider, practicing in Internal Medicine in Clearwater, Florida. Dr. Brown is rated as an Advanced provider by MediFind in the treatment of Cerebrotendinous Xanthomatosis. His top areas of expertise are Anemia, High Cholesterol, Sitosterolemia, Bone Graft, and Vertebroplasty. Dr. Brown is currently accepting new patients.

Nicholas Olney is a Neurologist and a Neuromusculoskeletal Medicine provider in Portland, Oregon. Dr. Olney is rated as an Advanced provider by MediFind in the treatment of Cerebrotendinous Xanthomatosis. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy Type 3, and Gastrostomy. Dr. Olney is currently accepting new patients.

Carly Hamlin is a primary care provider, practicing in Internal Medicine in Charlotte, North Carolina. Dr. Hamlin has been practicing medicine for over 11 years and is rated as an Experienced provider by MediFind in the treatment of Cerebrotendinous Xanthomatosis. Her top areas of expertise are Osteomyelitis in Children, Hypertension, Familial Hypertension, and Glucocorticoid-Remediable Aldosteronism.

Amro Stino, MD is an Associate Professor in the Department of Neurology in the University of Michigan Medical School, Division of Neuromuscular Medicine. Dr. Stino has expertise in the treatment of neuromuscular disorders, with special clinical and research interest in the care of patients with acquired peripheral neuropathy.A native of Ann Arbor, MI and a product of Ann Arbor schools, Dr. Stino went on to pursue a Bachelor of Science degree in Brain, Behavioral, and Cognitive Sciences from the University of Michigan, Ann Arbor, which he completed in 2006. He received his medical degree from Wayne State University, School of Medicine in Detroit, MI in 2010 and completed a transitional year internship at St. Joseph Mercy Hospital, in Ann Arbor, MI. He then completed his neurology residency training at the Wayne State University, School of Medicine – Detroit Medical Center, followed by a fellowship in clinical neurophysiology / neuromuscular medicine at The Mayo Clinic in Arizona. He joined The Ohio State University faculty in 2015 as Director of the Peripheral Neuropathy Clinic and Autonomic Lab. During his time there, he oversaw expansion of diagnostic testing and clinical operations of both, helping provide more comprehensive neuropathy care for central and southern Ohio patients seeking multi-disciplinary acquired neuropathy care. He helped obtain CIDP and CMT center of excellence accreditation. He joined the University of Michigan faculty in 2019 as Director of the Peripheral Neuropathy clinic and Co-director of the Autonomic Lab. Currently, he serves as site principal investigator on multi-center studies in the realms of metabolic and autoimmune neuropathy. He is presently conducting an investigator initiated phase 1b trial on the novel use of Lenalidomide in anti-MAG neuropathy.Dr. Stino is an advocate for patient awareness and education in autoimmune neuropathy and serves as physician liaison for the GBS-CIDP foundation, with whom he was interviewed on Good Day Columbus as part of GBS-CIDP awareness month. He also takes great interest in helping patients tackle peripheral neuropathy care in an evidence based fashion, particularly as it pertains to pain control.Dr. Stino enjoys working alongside and mentoring neuromuscular fellows, neurology residents, and medical students who rotate with him in clinic or inpatient service. He serves on the Peripheral Nerve Society Junior Board, which helps organize an annual educational course for attendees. His online videos on autoimmune neuropathy, small fiber neuropathy, and postural tachycardia syndrome have been viewed by thousands.He remains a dedicated Wolverine, despite having worked down south. Dr. Stino is rated as an Experienced provider by MediFind in the treatment of Cerebrotendinous Xanthomatosis. His top areas of expertise are Chronic Inflammatory Demyelinating Polyneuropathy, Peripheral Neuropathy, Chronic Polyradiculoneuritis, and Familial Dysautonomia.

Jeffrey Ratliff is a Neurologist in Philadelphia, Pennsylvania. Dr. Ratliff is rated as an Experienced provider by MediFind in the treatment of Cerebrotendinous Xanthomatosis. His top areas of expertise are Movement Disorders, Parkinson's Disease, Drug Induced Dyskinesia, Camptocormism, and Deep Brain Stimulation. Dr. Ratliff is currently accepting new patients.

Dr. Schiffmann is a renowned expert on neurometabolic diseases. He earned his medical degree from the University of Liège, Belgium and a Master of Health Sciences in Clinical Research from Duke University. He is board-certified in Neurology with a Special Qualification in Child Neurology and is a Fellow of the American Academy of Neurology. Dr. Schiffmann was a lead researcher at the United States National Institutes of Health in Bethesda, Maryland for over 17 years (1991-2007) and then the Director of the Institute of Metabolic Disease at the Baylor Scott & White Research Institute in Dallas, Texas, 2008-2019. Dr. Schiffmann is a Professor in the Department of Internal Medicine, Texas Christian University and a Clinical Professor, Texas A&M University Medical School College of Medicine. He is also a Senior Vice President for Clinical Research at 4D Molecular Therapeutics. Dr. Schiffmann has been performing pre-clinical and clinical research on lysosomal storage diseases since 1991 with a special focus on the natural history, pathogenesis and therapy of Fabry disease, Gaucher disease and the leukodystrophies. One of his particular interests and areas of expertise is to address patients with undiagnosed neurological diseases. Dr. Schiffmann has published 276 peer-reviewed research articles and over 15 book chapters. Dr. Schiffmann is rated as an Experienced provider by MediFind in the treatment of Cerebrotendinous Xanthomatosis. His top areas of expertise are Gaucher Disease Type 3, Fabry Disease, Gaucher Disease, and Leukodystrophy.

Dr. Charlotte Sumner is a Professor of Neurology and Neuroscience at Johns Hopkins University School of Medicine. Dr. Sumner cares for patients with genetically-mediated neuromuscular diseases. Her practice is notable for a focus on individuals with inherited neuromuscular disorders of peripheral nerves and motor neurons, including spinal muscular atrophy (SMA) and Charcot-Marie-Tooth (CMT) disease. She co-directs the Johns Hopkins Muscular Dystrophy Association Care Center, the Spinal Muscular Atrophy (SMA), and the Charcot-Marie-Tooth (CMT) clinics, which deliver multidisciplinary clinical care, engage in international natural history studies, and provide cutting edge therapeutics. Dr. Sumner’s research focuses on developing treatments for degenerative disorders of motor neurons and peripheral nerves. Her laboratory uses human tissues and induced pluripotent cell lines, mouse models and cultured cells to characterize disease mechanisms and develop treatments. Dr. Charlotte Sumner received her medical degree from the University of Pennsylvania School of Medicine following undergraduate studies at Princeton University. She completed internal medicine internship and neurology residency at the University of California San Francisco, after which she returned to the east coast for a neuromuscular fellowship at Johns Hopkins and a neurogenetics fellowship in the Neurogenetics Branch at the National Institute of Neurological Disorders and Stroke. She joined the neurology faculty at Johns Hopkins in 2006. Dr. Sumner is rated as an Experienced provider by MediFind in the treatment of Cerebrotendinous Xanthomatosis. Her top areas of expertise are Spinal Muscular Atrophy (SMA), Charcot-Marie-Tooth Disease, Primary Lateral Sclerosis, Spinal Muscular Atrophy Type 2, and Gastrostomy.

Dr. Ricardo Roda earned a combined MD/PhD degree from University of Rochester and completed an adult neurology residency, followed by a clinical neuromuscular fellowship at Johns Hopkins University School of Medicine. During residency, Dr. Roda developed a special interest in both auto-immune disorders and genetic disorders. Following residency, he spent three years in neurogenetics branch of National Institute of Neurological Disorders and Stroke (NINDS) working with Dr. Craig Blackstone, focusing on the use of the newer DNA sequencing techniques in genetic diagnosis, and in establishing genotype/phenotype correlations neuromuscular disorders. His current clinical interests include developing testing strategies for undiagnosed genetic disorders and myasthenia gravis. Dr. Roda is rated as an Experienced provider by MediFind in the treatment of Cerebrotendinous Xanthomatosis. His top areas of expertise are Spastic Paraplegia Type 7, Hereditary Spastic Paraparesis, Myasthenia Gravis, and Spastic Paraplegia Type 2.

Dr. Tom Crawford has been a member of the Department of Neurology since 1987. He is co-director of the MDA clinic for Neuromuscular Disorders and Neurologist for the Ataxia Telangiectasia Clinical Center at Johns Hopkins. His practice involves general child neurology with a principal interest in caring for children with neuromuscular, neuromotor, and ataxic disorders. Primary research interests involve the basic science and clinical characterization of two important neurologic disorders that affect children: Spinal Muscular Atrophy and Ataxia Telangiectasia. He is also actively involved in the Biology of neurofilaments by characterization of transgenic animal models. He is on the Medical and Scientific Advisory Boards of Families of Spinal Muscular Atrophy, and the Medical Advisory Committee for the Muscular Dystrophy Association. He is the Neurologist for the Ataxia Telangiectasia Clinical Center at Johns Hopkins, which has evaluated almost half of the known patients with this disorder in the United States. Additional specific clinical interests include evaluation and treatment of children with brachial plexus palsies. Dr. Crawford received his medical degree from the University of Southern California. He completed a pediatric internship and residency at the Pediatric Pavilion of the Los Angeles County / University of Southern California Medical Center, followed by a pediatric chief residency. He completed his training in Neurology with Special Qualification in Child Neurology at the Los Angeles Childrens Hospital. He then traveled east to the laboratory of Dr John Griffin at Johns Hopkins for a fellowship in Neuromuscular Disorders. Prior to medical training and Neurology residency, he majored in Psychology and Religion at Yale College. Dr. Crawford has published extensively and presented nationally and internationally. He has an active role in teaching medical students and residents in neurology. In addition, Dr. Crawford has special interest and experience in EMG studies of children and adults. Dr. Crawford is rated as an Experienced provider by MediFind in the treatment of Cerebrotendinous Xanthomatosis. His top areas of expertise are Primary Lateral Sclerosis, Spinal Muscular Atrophy (SMA), Ataxia-Telangiectasia, and Spinal Muscular Atrophy Type 2.

Saman Teymouri is a primary care provider, practicing in Internal Medicine in Sacramento, California. Dr. Teymouri is rated as an Experienced provider by MediFind in the treatment of Cerebrotendinous Xanthomatosis. His top areas of expertise are Anemia, High Cholesterol, Dyserythropoietic Anemia and Thrombocytopenia, and Gout. Dr. Teymouri is currently accepting new patients.